- Home
- VERV vs HLF Comparison
VERV vs HLF Comparison
Compare VERV & HLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERV
- HLF
- Stock Information
- Founded
- VERV 2018
- HLF 1980
- Country
- VERV United States
- HLF United States
- Employees
- VERV N/A
- HLF N/A
- Industry
- VERV Medicinal Chemicals and Botanical Products
- HLF Other Pharmaceuticals
- Sector
- VERV Health Care
- HLF Health Care
- Exchange
- VERV Nasdaq
- HLF Nasdaq
- Market Cap
- VERV 1.0B
- HLF 854.5M
- IPO Year
- VERV 2021
- HLF N/A
- Fundamental
- Price
- VERV $11.06
- HLF $10.18
- Analyst Decision
- VERV Buy
- HLF Strong Buy
- Analyst Count
- VERV 11
- HLF 4
- Target Price
- VERV $14.57
- HLF $11.50
- AVG Volume (30 Days)
- VERV 7.6M
- HLF 1.7M
- Earning Date
- VERV 08-07-2025
- HLF 08-06-2025
- Dividend Yield
- VERV N/A
- HLF N/A
- EPS Growth
- VERV N/A
- HLF 100.43
- EPS
- VERV N/A
- HLF 2.74
- Revenue
- VERV $59,613,000.00
- HLF $4,950,500,000.00
- Revenue This Year
- VERV $47.32
- HLF $0.10
- Revenue Next Year
- VERV N/A
- HLF $4.12
- P/E Ratio
- VERV N/A
- HLF $3.78
- Revenue Growth
- VERV 271.44
- HLF N/A
- 52 Week Low
- VERV $2.87
- HLF $5.04
- 52 Week High
- VERV $11.41
- HLF $12.79
- Technical
- Relative Strength Index (RSI)
- VERV 78.23
- HLF 70.07
- Support Level
- VERV $11.16
- HLF $9.63
- Resistance Level
- VERV $11.30
- HLF $10.56
- Average True Range (ATR)
- VERV 0.12
- HLF 0.42
- MACD
- VERV -0.18
- HLF 0.13
- Stochastic Oscillator
- VERV 12.50
- HLF 87.03
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.